The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Update - March 2022

27 Apr 2022 07:00

RNS Number : 4241J
Honeycomb Investment Trust PLC
27 April 2022
 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

27 April 2022

Honeycomb Investment Trust plc

Honeycomb Investment Trust plc (the "Company" or "Honeycomb") announces that the Investment Manager's monthly factsheet for 31 March 2022 is now available on its website at http://www.honeycombplc.com.

Net Asset Value per Share

The Company announces that its unaudited Net Asset Value ("NAV") per share as at 31 March 2022 on a cum-income basis was 1,019.0 pence, based on a NAV of £358.9 million, and on an ex-income basis was 1,018.0 pence, based on a NAV of £358.5 million. The NAVs have been calculated by Apex Fund Services (UK) Ltd.

Honeycomb delivered a NAV return of 0.66% for the month, which is equivalent to 7.8% per annum. NAV return was driven by strong risk adjusted yield of 9.0%. This is in-line with the Q1 total risk adjusted yield, driving a 7.9% NAV return for the quarter.

Net Investment Assets increased in the month to £586m, from £580m at the end of Feb. This was driven by drawdowns on a senior electric vehicle fleet financing facility as well as net deployment of £7.3m across the senior real estate debt facilities.

The pipeline of new opportunities is strong with c£400m of well progressed deals across Europe and is diversified across a range of sub sectors including micro mobility, small balance SME loans and insurance run off financing. Whilst the outlook for our target market remains positive, the manager Pollen Street Capital remains very focused on the broader macro-economic environment. PSC also continues to see opportunities in sustainability-oriented sectors offering attractive risk adjusted returns whilst also making a positive impact from an ESG perspective.

Despite the more challenging macro-outlook, PSC believes that asset backed direct lending represents a resilient asset class that delivers strong relative value versus other private credit opportunities and publicly traded comparables. The combination of asset backing via large diverse pools of financial and hard assets along with bespoke structuring delivers strong downside protection with a significant margin of safety as well as premium returns.

Proprietary data systems and comprehensive data collection provide the manager with regular and detailed data, and strong transparent relationships with our lending partners enable the manager to closely monitor underlying performance. Detailed monitoring of the portfolio provides reassurance that, despite broader economic concerns, the investment portfolio remains in a strong position.

In response to the unfortunate events in Ukraine, the Honeycomb Board reported, on 11 March 2022, that the Company does not have any direct exposure to Russia. Further, the Company announced, via an RNS on 21 March, that it now intends to commence a share buyback programme, commencing on that date and expected to end no later than 29 April 2022. The policy is to consider conducting share buybacks when trading at a discount of more than 5%. Details of the ongoing programme are updated through RNS postings on the London Stock Exchange.

Finally, the Board was pleased to note that Capital Finance International magazine has named Pollen Street Capital Best Responsible Alternative Investment Team UK for the second consecutive year. The judging panel also noted Pollen Street Capital's prioritisation of lasting impact backing companies and credit partners that help consumers to make greener choices, increase their access to finance and SMEs to promote job creation and socioeconomic growth.

For further information about this announcement please contact:

Pollen Street Capital - Investment Manager

Matthew Potter / Julian Dale: +44 (0)20 3728 6750

Liberum Capital Limited - Joint Broker

Chris Clarke: +44 (0)20 3100 2000 

Cenkos Securities plc - Joint Broker

Justin Zawoda-Martin: +44 (0)20 7397 8900

Link Company Matters Limited - Corporate Secretary

hitcosec@linkgroup.co.uk 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVBUGDSSXDDGDL
Date   Source Headline
7th Oct 20227:00 amRNSChange of Name
5th Oct 20225:11 pmRNSHolding(s) in Company
5th Oct 20225:11 pmRNSHolding(s) in Company
5th Oct 20225:07 pmRNSHolding(s) in Company
5th Oct 20225:04 pmRNSHolding(s) in Company
5th Oct 202212:01 pmRNSDirector/PDMR Shareholding
4th Oct 20226:23 pmRNSHolding(s) in Company
4th Oct 20225:44 pmRNSHolding(s) in Company
4th Oct 20225:10 pmRNSHolding(s) in Company
4th Oct 20224:53 pmRNSHolding(s) in Company
4th Oct 202212:07 pmRNSHolding(s) in Company
4th Oct 202211:29 amRNSHolding(s) in Company
30th Sep 20228:12 amRNSCompletion of the Combination with Pollen Street
26th Sep 20222:40 pmRNSPublication of a Prospectus
14th Sep 20224:44 pmRNSChange Of Latest DRIP Election Date
13th Sep 20227:45 amRNSHalf-year Report
6th Sep 20221:48 pmRNSDividend Declaration
6th Sep 20227:00 amRNSNAV and Monthly Update - July 2022
3rd Aug 20227:00 amRNSMonthly Update - June 2022
25th Jul 20227:00 amRNSAppointment of Corporate Broker
29th Jun 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Jun 20227:00 amRNSNAV and Monthly Update - May 2022
22nd Jun 20224:12 pmRNSResult of AGM
22nd Jun 20227:00 amRNSTransaction in Own Shares & Total Voting Rights
17th Jun 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Jun 20224:10 pmRNSResults of General Meeting
26th May 20227:00 amRNSNAV and Monthly Update – April 2022.
18th May 20224:22 pmRNSPosting of Annual Report and Notice of AGM
18th May 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
10th May 20222:36 pmRNSCircular and Notice of General Meeting
6th May 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Apr 20227:00 amRNSShare Buyback Programme Extension
27th Apr 20227:00 amRNSMonthly Update - March 2022
26th Apr 20224:34 pmRNSDividend Declaration
7th Apr 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Mar 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20227:01 amRNSTransaction in Own Shares
21st Mar 20227:00 amRNSMonthly Update - February 2022
11th Mar 20223:21 pmRNSRussian Exposure
2nd Mar 20227:01 amRNSAnnual Financial Report
2nd Mar 20227:00 amRNSCapital Markets Day
2nd Mar 20227:00 amRNSStatement re Share Buyback
24th Feb 20227:00 amRNSNotice of upcoming Capital Markets Event
23rd Feb 20222:34 pmRNSDirector Declaration
23rd Feb 20222:28 pmRNSDividend Declaration
15th Feb 20227:00 amRNSHoneycomb combination with Pollen Street Capital
31st Jan 20227:00 amRNSMonthly Update - December 2021
23rd Dec 20217:00 amRNSNAV and Monthly Update - November 2021
24th Nov 20211:13 pmRNSDividend Declaration
23rd Nov 20217:00 amRNSNAV and Monthly Update - October 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.